These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 10232585)

  • 1. Genetic deletion of p21WAF1 enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis.
    Weinberg WC; Fernandez-Salas E; Morgan DL; Shalizi A; Mirosh E; Stanulis E; Deng C; Hennings H; Yuspa SH
    Cancer Res; 1999 May; 59(9):2050-4. PubMed ID: 10232585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM; Spalding JW; Tennant RW; Smart RC
    Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
    Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
    Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
    Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
    Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
    La E; Muga SJ; Locniskar MF; Fischer SM
    Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of malignant conversion in skin carcinogenesis.
    Yuspa SH; Greenhalgh DA
    Princess Takamatsu Symp; 1989; 20():281-8. PubMed ID: 2518687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis.
    Wang XJ; Greenhalgh DA; Jiang A; He D; Zhong L; Medina D; Brinkley BR; Roop DR
    Oncogene; 1998 Jul; 17(1):35-45. PubMed ID: 9671312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ-specific, carcinogen-induced increases in cell proliferation in p53-deficient mice.
    Sukata T; Ozaki K; Uwagawa S; Seki T; Wanibuchi H; Yamamoto S; Okuno Y; Fukushima S
    Cancer Res; 2000 Jan; 60(1):74-9. PubMed ID: 10646856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of p21CIP1/WAF1 does not recapitulate accelerated malignant conversion caused by p53 loss in experimental skin carcinogenesis.
    Weinberg WC; Montano NE; Deng C
    Oncogene; 1997 Aug; 15(6):685-90. PubMed ID: 9264409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
    Wang XJ; Liefer KM; Greenhalgh DA; Roop DR
    Mol Carcinog; 1999 Dec; 26(4):305-11. PubMed ID: 10569807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
    Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D
    Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis.
    Philipp J; Vo K; Gurley KE; Seidel K; Kemp CJ
    Oncogene; 1999 Aug; 18(33):4689-98. PubMed ID: 10467416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 gene dosage modifies growth and malignant progression of keratinocytes expressing the v-rasHa oncogene.
    Weinberg WC; Azzoli CG; Kadiwar N; Yuspa SH
    Cancer Res; 1994 Nov; 54(21):5584-92. PubMed ID: 7923201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic susceptibility to tumor progression in mouse skin carcinogenesis.
    Stern MC; Conti CJ
    Prog Clin Biol Res; 1996; 395():47-55. PubMed ID: 8895983
    [No Abstract]   [Full Text] [Related]  

  • 15. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
    Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
    Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte.
    Woodworth CD; Michael E; Smith L; Vijayachandra K; Glick A; Hennings H; Yuspa SH
    Carcinogenesis; 2004 Sep; 25(9):1771-8. PubMed ID: 15105299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis.
    Gebhardt C; Breitenbach U; Tuckermann JP; Dittrich BT; Richter KH; Angel P
    Oncogene; 2002 Jun; 21(27):4266-76. PubMed ID: 12082614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin.
    Hsieh YH; Juliana MM; Hicks PH; Feng G; Elmets C; Liaw L; Chang PL
    Cancer Res; 2006 Jul; 66(14):7119-27. PubMed ID: 16849558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mice expressing epidermal-targeted v-fos induces rasHA-activated papillomas and carcinomas without p53 mutation: association of v-fos expression with promotion and tumor autonomy.
    Greenhalgh DA; Wang XJ; Eckhardt JN; Roop DR
    Cell Growth Differ; 1995 May; 6(5):579-86. PubMed ID: 7544154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metallothionein deficiency enhances skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate in metallothionein-null mice.
    Suzuki JS; Nishimura N; Zhang B; Nakatsuru Y; Kobayashi S; Satoh M; Tohyama C
    Carcinogenesis; 2003 Jun; 24(6):1123-32. PubMed ID: 12807749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.